Skip to content

Investigating the effect of lavender (Lavandula angustifolia) inhalation aroma therapy on stress, anxiety and depression of addicts

Investigating the effect of lavender (Lavandula angustifolia) inhalation aroma therapy on stress, anxiety and depression of addicts under treatment hospitalized in the addiction wards

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141127020108N9
Enrollment
56
Registered
2025-06-12
Start date
2025-07-11
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug addiction. Alcoholism and drug addiction in family

Interventions

Intervention 1: Intervention group: In the Intervention group, the samples participating in the study were subjected to aromatherapy with lavender essential oil for 3 days at 10 am and 6 pm. Thus, the

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years and above be able to read and write in Persian. Consent to participate in the study.

Exclusion criteria

Exclusion criteria: Having a history of allergic rhinitis, eczema, or known respiratory problems such as asthma Having a cold or anything else that affects a person's ability to smell.

Design outcomes

Primary

MeasureTime frame
Anxiety. Timepoint: Immediately before and three days after the start of the intervention. Method of measurement: Stress, Anxiety, Depression Questionnaire (DASS-21).;Depression. Timepoint: Immediately before and three days after the start of the intervention. Method of measurement: Stress, Anxiety, Depression Questionnaire (DASS-21).;Stress. Timepoint: Immediately before and three days after the start of the intervention. Method of measurement: Stress, Anxiety, Depression Questionnaire (DASS-21).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Musarezaie

Esfahan University of Medical Sciences

musarezaie@nm.mui.ac.ir+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026